Vitamin D Research
back to research menu
Liver Function
- The Basic Helix-loop-helix Proteins DEC1 and DEC2 Function as Corepressors of Retinoid X Receptors. Mol Pharmacol. 2009 Sep 28.
- Inverse association between serum concentrations of actin-free vitamin D-binding protein and the histopathological extent of fibrogenic liver disease or hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2009 Sep;21(9):990–5.
- Bile acids as regulatory molecules. J Lipid Res. 2009 Aug;50(8):1509–20. Review.
- Bone mineral density and disorders of mineral metabolism in chronic liver disease. World J Gastroenterol. 2009 Jul 28;15(28):3516–22.
- Premature aging in vitamin D receptor mutant mice. J Steroid Biochem Mol Biol. 2009 Jul;115(3–5):91–7.
- The Evaluation of Secondary Causes of Bone Loss in a Primary Care Setting. Endocr Pract. 2009 May 6:1–16.
- Liver X receptors control IgE expression in B cells. J Immunol. 2009 May 1;182(9):5276–82.
- Drug-induced hypersensitivity syndrome: clinical and biologic disease patterns in 24 patients. Medicine (Baltimore). 2009 May;88(3):131–40.
- Mechanism of vitamin D receptor inhibition of cholesterol 7alpha-hydroxylase gene transcription in human hepatocytes. Drug Metab Dispos. 2009 Mar;37(3):469–78.
- Medical treatment of primary sclerosing cholangitis: a role for novel bile acids and other (post–)transcriptional modulators? Clin Rev Allergy Immunol. 2009 Feb;36(1):52–61. Review.
- The clinical significance of gastrointestinal changes with aging. Curr Opin Clin Nutr Metab Care. 2008 Sep;11(5):651–60.
- Vitamin D insufficiency in children, adolescents, and young adults with cystic fibrosis despite routine oral supplementation. Am J Clin Nutr. 2007 Dec;86(6):1694–9.
- Vitamin D insufficiency/deficiency in gastrointestinal disorders. J Bone Miner Res. 2007 Dec;22 Suppl 2:V50–4. Review.
- Vitamin D and its implications for musculoskeletal health in women: An update. Maturitas. 2007 Oct 20;58(2):117–37. Review.
- Cholecalciferol significantly increases 25-hydroxyvitamin D concentrations in adults with cystic fibrosis. Am J Clin Nutr. 2007 May;85(5):1307–11.
- Vitamin D and Parathyroid Hormone in Outpatients With Noncholestatic Chronic Liver Disease. Clin Gastroenterol Hepatol. 2007 Apr;5(4):513–20.
- Nutritional vitamin D deficiency presenting as hemichorea. J Child Neurol. 2007 Jan;22(1):74–6.
- Chronic contamination with 137Cesium affects Vitamin D3 metabolism in rats. Toxicology. 2006 Aug 1;225(1):75–80.
- Effects of depleted uranium after short-term exposure on vitamin D metabolism in rat. Arch Toxicol. 2006 Aug;80(8):473–480.
- Osteoporotic fractures and vitamin D deficiency. Aust Fam Physician. 2006 Jul;35(7):519–20, 522.
- Association between vitamin D receptor, CCR5, TNF-alpha and TNF-beta gene polymorphisms and HBV infection and severity of liver disease. J Hepatol. 2006 May;44(5):856–63.
- Short-term hepatic effects of depleted uranium on xenobiotic and bile acid metabolizing cytochrome P450 enzymes in the rat. Arch Toxicol. 2006 Apr;80(4):187–95.
- Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia J Clin Invest. 116:1703–1712 (2006) March.
- Vitamin D for health and in chronic kidney disease. Semin Dial. 2005 Jul–Aug;18(4):266–75. Review.
- Disturbances of calcium-PTH-vitamin D axis in chronic liver diseases. Arq Bras Endocrinol Metabol. 2004 Aug;48(4):443–50. Review.
- Disorders of bone metabolism in gastrointestinal and hepatic diseases. Ned Tijdschr Geneeskd. 2000 Mar 4;144(10):462–7. Review.
- Liver granulomatosis is not an exceptional cause of hypercalcemia with hypoparathyroidism in dialysis patients. J Nephrol. 1999 Nov–Dec;12(6):398–403.
- Saccharated ferric oxide (SFO)-induced osteomalacia: in vitro inhibition by SFO of bone formation and 1,25-dihydroxy-vitamin D production in renal tubules. Bone. 1997 Jul;21(1):57–64.
- Metabolic bone disease in gastrointestinal, hepatobiliary, and pancreatic disorders and total parenteral nutrition. Curr Opin Rheumatol. 1995 May;7(3):249–54. Review.
- Massive hepatomegaly, steatosis, and secondary plasma carnitine deficiency in an infant with cystic fibrosis. Pediatrics. 1989 Jun;83(6):993–7.
- Main endocrine modulators of vitamin D hydroxylases in human pathophysiology. J Steroid Biochem. 1987;27(4–6):815–24. Review.
- Metabolism of vitamin D in patients with primary biliary cirrhosis and alcoholic liver disease. Clin Sci (Lond). 1985 Nov;69(5):561–70.
- Vitamin D metabolism and osteomalacia in cystic fibrosis. Gastroenterology. 1985 Mar;88(3):808–13.
- A survey of vitamin D deficiency in gastrointestinal and liver disorders. Q J Med. 1984 Winter;53(209):119–34.
- Vitamin D metabolism and chronic liver disease. Ann Clin Lab Sci. 1984 May–Jun;14(3):189–97. Review.
- Serum vitamin D metabolites in epileptic patients treated with 2 different anti-convulsants. Acta Neurol Scand. 1982 Sep;66(3):335–41.
- Osteomalacia, vitamin D deficiency and cholestasis in chronic liver disease. Q J Med. 1982;51(201):89–103.
- Vitamin D in chronic liver disease. Prog Liver Dis. 1979;6:539–55. Review.
- Case report: hypoparathyroidism and iron storage disease. Treatment with 25-hydroxyvitamin D3. Am J Med Sci. 1978 Nov–Dec;276(3):363–8.
- Vitamin D: the discovery of its metabolites and their therapeutic applications. Pediatrics. 1976 May;57(5):729–41. Review.
back to research menu